The Aminopyrine Breath Test and Serum Bile Acids Reflect Histologic Severity in Chronic Hepatitis

To determine whether the aminopyrine breath test (ABT) and serum bile acid concentrations reflect histologic severity of chronic hepatitis, 56 patients were prospectively evaluated with liver biopsies and ABTs, and the results were compared to results of standard liver chemistry tests; 44 of these patients also had fasting and 2‐hr postprandial serum bile acid measurements. Mean values for the ABT were significantly lower, and serum bile acids were significantly higher in patients with chronic active hepatitis with bridging or cirrhosis than in patients with mild chronic active hepatitis or chronic persistent hepatitis. Thirty of 35 patients with bridging or cirrhosis had ABTs <5.7% (mean of controls –2 S.D.) and 21 of 25 with mild chronic active hepatitis or chronic persistent hepatitis had values >5.7% (sensitivity 0.86, specificity 0.84). Fasting and 2–hr postprandial bile acids were also more sensitive than standard chemistries in identifying patients with bridging or cirrhosis. Thus, the ABT and serum bile acids reflect histologic severity in chronic hepatitis patients and may be helpful in selecting patients for liver biopsy.

[1]  J. Hoefs,et al.  Determinants of serum bile acids in chronic liver disease. , 1981, Gastroenterology.

[2]  J. Saunders,et al.  Predicting outcome of paracetamol poisoning by use 14C-aminopyrine breath test. , 1980, British medical journal.

[3]  E. Piken,et al.  Decreased hepatic microsomal reserve in patients with cirrhosis. Studies using aminopyrine as model drug. , 1979, The Journal of laboratory and clinical medicine.

[4]  L. Powell,et al.  Drug metabolism in liver disease: Activity of hepatic microsomal metabolizing enzymes , 1979, Clinical pharmacology and therapeutics.

[5]  D. Schoeller,et al.  A microprocessor controlled mass spectrometer for the fully automated purification and isotopic analysis of breath carbon dioxide. , 1979, Biomedical mass spectrometry.

[6]  J. Boyer,et al.  Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. , 1978, Gastroenterology.

[7]  D. Schoeller,et al.  Validation of 13CO2 breath analysis as a measurement of demethylation of stable isotope labeled aminopyrine in man. , 1978, Clinica chimica acta; international journal of clinical chemistry.

[8]  S. Sherlock,et al.  Assessment of the (14C) aminopyrine breath test in liver disease. , 1978, Gut.

[9]  P. Ross,et al.  Serum bile acids in the diagnosis of hepatobiliary disease. , 1977, Gut.

[10]  A. Lipton,et al.  Abnormal aminopyrine metabolism in patients with hepatic neoplasm. Detection by breath test. , 1976, JAMA.

[11]  J. Bircher,et al.  Aminopyrine demethylation measured by breath analysis in cirrhosis , 1976, Clinical pharmacology and therapeutics.

[12]  J. Boyer,et al.  Chronic hepatitis--a perspective on classification and determinants of prognosis. , 1976, Gastroenterology.

[13]  J. Bircher,et al.  Expiratory measurement of maximal amino-pyrine demethylation in vivo: effect of phenobarbital, partial hepatectomy, protacaval shunt and bile duct ligation in the rat. , 1976, The Journal of pharmacology and experimental therapeutics.

[14]  E. Vesell,et al.  Quantitative assessment of hepatic function by breath analysis after oral administration of (14C)aminopyrine. , 1975, Annals of internal medicine.

[15]  E. Vesell,et al.  Assessment of aminopyrine metabolism in man by breath analysis after oral administration of 14C-aminopyrine. Effects of phenobarbital, disulfiram and portal cirrhosis. , 1974, The New England journal of medicine.

[16]  A. Hofmann,et al.  Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology. , 1974, The New England journal of medicine.

[17]  N. Kaplowitz,et al.  Postprandial serum bile acid for the detection of hepatobiliary disease. , 1973, JAMA.

[18]  Rupert G. Miller.  Simultaneous Statistical Inference , 1967 .

[19]  O. Ljungberg,et al.  Medullary thyroid carcinoma and phaeochromocytoma: a familial chromaffinomatosis. , 1967, British medical journal.

[20]  J. W. Gorman,et al.  Selection of Variables for Fitting Equations to Data , 1966 .

[21]  R. P. Thompson,et al.  Direct measurement of hepatic extraction of bile acids in subjects with and without liver disease. , 1981, Clinical science.

[22]  J. Schäffer,et al.  14C-D-galactose breath test for evaluation of liver function in patients with chronic liver disease. , 1978, Digestion.

[23]  D. Schoeller,et al.  A simplified technique for collecting breath CO2 for isotope ratio mass spectrometry. , 1978, Biomedical mass spectrometry.

[24]  O. Fausa,et al.  Serum bile acid concentrations in patients with liver disease. , 1976, Scandinavian journal of gastroenterology.

[25]  L. Elveback,et al.  Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution. , 1972, Human pathology.